Streetbeat News

Analyst Ratings

PSFE

UBS analyst Timothy Chiodo maintains a Sell rating on Paysafe (NYSE:PSFE) and lowers the price target from $12 to $11.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:10 pm

FIHL

Citigroup analyst Michael Ward has maintained a Buy rating on Fidelis Insurance Holdings (FIHL) and increased the price target from $17 to $21.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:05 pm

HG

Citigroup analyst Michael Ward has maintained a Buy rating on Hamilton Insurance Group (NYSE:HG) and increased the price target from $19 to $20.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:03 pm

DKS

Barclays analyst Adrienne Yih maintains an Overweight rating on Dick's Sporting Goods (DKS) and raises the price target from $179 to $194.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:59 pm

REGN

Bernstein analyst Aaron Gal initiates coverage on Regeneron Pharmaceuticals (NASDAQ:REGN) with an Outperform rating and a price target of $1125.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:44 pm

MDB

MongoDB Inc (NASDAQ:MDB) reported Q4 earnings with significant EPS and revenue surprises but saw its stock drop 7% due to disappointing guidance. Despite a strong yearly return, the stock is down over 10% this year. Technical indicators suggest a bearish trend, with the stock trading below key EMAs and SMAs. However, the MACD indicates bullishness, while the RSI suggests the stock is oversold. Analyst consensus rates MDB as a Buy with a target price of $439.18.

Portfolio Pulse from Surbhi Jain

March 11, 2024 | 8:34 pm

SCHW

Recent options trading activity indicates a bearish sentiment towards Charles Schwab (NYSE:SCHW), with 66% of detected trades being bearish. The trading range for SCHW is projected between $65.0 and $72.5 over the next three months. Notable options activity includes both puts and calls with varying sentiments and expiration dates. Charles Schwab, a major player in brokerage and wealth management, has over $7 trillion in client assets. The stock is currently down by -0.33% at $66.95, with an RSI indicating it may be approaching overbought. An analyst from Barclays has set a target price of $68.0, maintaining an Equal-Weight rating.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:30 pm

IVV

SPY

VOO

Bank of America analysts have raised the S&P 500's one-year price target from 5000 to 5400, expecting a 13% yield in the next 12 months despite concerns of a potential market bubble. Analyst Savita Subramanian argues that current market conditions resemble those of the mid-90s rather than a bubble, citing neutral U.S. equity sentiment and the nascent state of tech subsectors like AI. The S&P 500's performance is tracked by ETFs such as SPY, VOO, and IVV.

Portfolio Pulse from Natan Ponieman

March 11, 2024 | 8:10 pm

SAP

Analyst ratings for SAP (NYSE:SAP) have shown a mix of opinions over the last three months, with recent updates indicating a positive shift in sentiment. The average 12-month price target for SAP has been raised to $198.2, marking a 16.45% increase from the previous target. This adjustment reflects analysts' growing optimism about SAP's market performance, despite the company facing challenges in revenue growth, net margin, ROE, ROA, and debt management compared to industry averages.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:00 pm

KALV

Needham analyst Serge Belanger maintains a Buy rating on KalVista Pharma (NASDAQ:KALV) with a maintained price target of $35.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 7:52 pm